5th International Congress on Maternal Hemodynamics 2024
45 $
Format : 8 videos
File size: 12.6 GB
The International Working Group on Maternal Hemodynamics is glad to announce the upcoming Fifth International Congress on Maternal Hemodynamics, which will be held in Florence 7-9 March 2024. Free communications will be presented in the plenary sessions together with lectures from international experts in the field. We have allowed time to encourage interaction and discussion of all of these presentations. Abstracts will be published on the Italian Journal of Gynaecology and Obstetrics. The congress will be an opportunity to share the latest research in the field of cardiovascular system before, during and after pregnancy. The main sessions that will be treated during the congress. Methodology for the detection of maternal hemodynamics; long term cardiovascular consequences of maternal fetal complications in preg-nancy; hemodynamics in fetal growth restriction, twin pregnancy/IVF, hypertensive disorders of pregnancy and preeclampsia, labour, and diabetes; obstetric anesthesia and maternal hemodynamics; hemodynamics as an help for medical treatment in hypertensive disease. The International Working Group on Maternal Hemodynamics is an international association of Obstetricians, Cardiovascular Physicians and researchers from all over the world interested in the cardiovascular system adaptation during pregnancy and its relation to maternal and fetal outcome.
The 5th International Congress on Maternal Hemodynamics 2024 is designed for a diverse group of professionals interested in the cardiovascular system’s adaptation during pregnancy and its impact on maternal and fetal outcomes. The target audience includes:
- Obstetricians
- Cardiovascular physicians
- Researchers
- Healthcare professionals involved in maternal and fetal care
This congress provides an opportunity to share the latest research and advancements in maternal hemodynamics, fostering interaction and discussion among experts in the field.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
SESSION 1 – Methodology how to collect data in a proper way.mp4
SESSION 2 – Long term consequences andSESSION 3 – Hemodynamics in Fetal Growth restriction.mp4
SESSION 4 – Basic research.mp4
SESSION 5 – Labor.mp4
SESSION 6 – Obstetric Anesthesia and SESSION 7 – Diabetes in Pregnancy.mp4
SESSION 8 – Medical treatment in hypertensive disease let’s have some help from hemodynamics.mp4
SESSION 9 – Twin pregnancy IVF.mp4
SESSION 10 – HDP-Preeclampsia.mp4
* Detail:
Thursday, March 7th
14:00-14:10 Welcome Prof. F. Mecacci; Prof. H. Valensise
14:10-15:00 SESSION 1 – Methodology: how to collect data in a proper way Chairman W. Gyselaers (I. Wilkinson)
14:10-14:30 Blood pressure measurement and/or hemodynamics assessment: what should we do? W. Gyselaers
14:30-14:50 The role of POCUS in Maternal Medicine J. Cornette
14:50-15:10 The Femtech Revolution-Reshaping and digitalizing women’s-Improving Global Maternal Offspring Outcome M. Hod
15:10-15:20 Discussion
15:20-15:40 The modern maternal hemodynamic features for prediction of preeclampsia Dmytro Konkov
Plasma renin concentration throughout healthy and hypertensive pregnancy: a systematic review and meta-analysis Maaike van Ochten
On the pathogenesis of preeclampsia: a new pre-pregnancy risk factor for preterm and term preeclampsia and evidence from recurrences supporting their common origin. Svitlana Arbuzova
15:40-16:00 Coffee break
16:00-17:30 SESSION 2 – Long term consequences Chairman: B. Thilaganathan- C. Ghossein-Doha
16:00-16:20 Optimising maternal cardiovascular health outcomes in preeclampsia B. Thilaganathan
16:20-16:40 Diversity in CV Medicine, beyond the gender perspective C. Ghossein-Doha
16:40-17:00 Pre-eclampsia and long term cardiovascular morbidity: cause or association? C. McEniery
17:00-17:10 Discussion
17:10-17:35 Early third trimester maternal cardiac morphometry in high-risk pregnancies of placental insufficiency Judit Martinez-Egea
First trimester maternal hemodynamics in patients with or without chornic hypertension Hyunyoung Ahn
Associations Between Blood Pressure Variability and Perinatal Outcomes Natalia Boscaneanu
17:35-18:40 SESSION 3 – Hemodynamics in Fetal Growth restriction Chairman: J. Cornette- H.Valensise
17:35-17:55 Preclinical hemodynamic profile in early and late FGR B. Vasapollo
17:55-18:15 Modelling for prediction of outcome in Late FGR R. Napolitano
18:15-18:25 Discussion
18:25-18:55 Postpartum maternal cardiac adaptation in SGA pregnancies and its correlation with biomarkers of cardiovascular risk Eva Meler
Use of Antihypertensive Medications at Discharge and in the Immediate Postpartum Period: Observations from a Cohort of Hypertensive Pregnant Patients at a Canadian Tertiary Centre Kelsey McLaughlin
Baroreceptor mediated blood pressure control in women with a history of preeclampsia Nadine Boutkan
Friday, March 8th
08:30-10:00 SESSION 4 – Basic research Chairman: T. Mousa-C. McEniery
08:30-08:50 Oxygen and glucose supply in human fetal growth restriction I. Cetin
08:50-09:10 Umbilical Venous flow and maternal hemodynamics D. Farsetti
09:10-09:30 New predictors for hypertensive disorders of pregnancy D.D. Di Martino
09:30-09:50 Does a mother’s heart know? E. J Stohr
09:50-10:00 Discussion
10:00-10:30 The impact of obesity on maternal hemodynamics… Pouya Abhari
Evaluating Trajectories of Placental Growth Factor (PlGF) and Pregnancy Outcomes Following Multimodal Screening for Preeclampsia. John Snelgrove
Study protocol for the randomized controlled TREASURE trial: timely recovery after subclinical heart failure Zenab Mohseni-Alsalhi
Early-life consequences of Hypertensive Disorders during Pregnancy: an exploration of the retinal microvasculature in young children. Hanne Sleurs
10:30-11:00 Coffee Break
11:00-12:30 SESSION 5 – Labor Chairman: H. Valensise
11:00-11:20 Fetal cardiac function in active labor T. Ghi
11:20-11:40 Maternal hemodynamics during labor with epidural anesthesia S. Giannubilo
11:40-12:00 Maternal hemodynamics in the delivery room A. Dall’Asta
12:00-12:20 Fetal cardiac function: new tools T. Stampalja
12:20-12:30 Discussion
12:30-13:00 Association between nadverse neonatal outocom and maternal haemodynamics Christoph Lees
Preconception physical activity alters the cardiovascular profile of women at risk for gestational hypertensive disorders in a profile-specific way. Pauline Dreesen
Arterial stiffness and endothelial function after preeclampsia: can they predict the outcome of the subsequent pregnancy? Ellen Faes
Non-invasive maternal hemodynamics for the classification of pregnancies complicated by fetal growth restriction Andrea Caricati
13:00-14:00 Light Lunch
14:00-15:50 SESSION 6 – Obstetric Anesthesia Chairman: M. Micaglio, G.P. Novelli
14:00-14:20 Hemodynamic impact of neuraxial anesthesia for CS M. Van de Velde (online)
14:20-14:40 Maternal Hemodynamic changes in pregnancy: what’s new? L. Lorini
14:40-15:00 Update on fluid management in the pregnant patient L. Frassanito
15:00-15:20 Homeostasis and noninvasive macrocirculation evaluation in pregnant patient M. Micaglio
15:20-15:40 Cardiac output-guided maternal positioning might improve pregnancy outcomes T. Archer
15:40-15:50 Discussion
15:50-17:00 SESSION 7 – Diabetes in Pregnancy Chairman: F. Mecacci; Michael Paidas
15:50-16:10 Phenotipic eterogeneity of GDM: what is the relationship with the cardiovascular function F. Mecacci
16:10-16:30 Routine mid gestation oral glucose tolerance test ‘plus’ to predict later preeclampsia M. Spanderman
16:30-16:50 Changes in arterial stiffness among women with gestational diabetes T. Mousa
16:50-17:00 Discussion
17:00-17:30 Coffee Break
17:30-19:00 SESSION 8 – Medical treatment in hypertensive disease: let’s have some help from hemodynamics Chairman: M. Spanderman
17:30-17:50 Why management of PE must be tailored C. Lees
17:50-18:10 Hypodynamic hypertension in pregnancy: update on treatment. G.P Novelli
18:10-18:20 Why understanding pharmocokientics of anti hypertensive medications is important I. Wilkinson
18:20-18:40 The potential of Pentaerytrithyltetranitrate PETN in pregnancies complicated by impaired placental perfusion and maternal hemodynamics T. Groten
18:40-19:00 Maternal hemodynamics in GUCH pregnancies F. Prefumo
19:00-19:10 Discussion
Saturday, March 9th
08:30-09:40 SESSION 9 – Twin pregnancy/IVF Chairman: A. Khalil; F. Mecacci
08:30-08:50 Screening for preeclampsia in twin pregnancies D. Schlembach
08:50-09:10 Hemodynamic and cardiac changes during twin vs singleton pregnancy R. Orabona
09:10-09:30 Preeclampsia in twins how different from singletons A. Khalil (online)
09:30-09:40 Discussion
09:40-10:20 Circulating Angiogenic Factors levels in women with Hypertensive Disorders of Pregnancy (HPD) according to the baseline hemodynamic findings Beatrice Valentini
The correlation between first-trimester serum biochemical and biophysical markers and skin microvascular reactivity assessed by laser speckle contrast imaging Mor Huri
Maternal and fetal hemodynamics assessment to predict IUGR in twin Pregnancies Benedetta Lupoli
Small-for-gestational-Age Fetuses characteristics and outcome in pregnancies complicated by gestational diabetes Sara Nardini (recorded)
Association between adverse neonatal outcome and maternal haemodynamics and biomarkers in SGA and FGR Bronacha Mylrea-Foley
Physical activity during pregnancy: maternal hemodynamics and obstetrics outcomes Anna Luna Tramontano
10:20-10:50 Coffee Break
10:50-11:20 The role of umbilical vein blood flow assessment in the prediction of fetal growth: a prospective observational cohort study Daniele Farsetti
Haemodynamic evaluation in pregnancies complicated by T1DM (Type 1 Diabetes Mellitus): differences in LGA (Large for Gestational Age) vs AGA (Appropriate for Gestational Age) newborns Benedetta Baggio
Maternal hemodynamics in placental implantation abnormalities: a pilot study Filomena Maellaro
Hemodynamic and impedenzometric profile in low-risk pregnant women at term with excessive gestational weight gain. A pilot study Teresa Aiolfi
11:20-12:30 SESSION 10 – HDP-Preeclampsia Chairman: C. Lees- E. Ferrazzi
11:20-11:40 Do all women after HDP have the same long-term risk of CVD in later life? J.J. Duvekot
11:40-12:00 Cardiovascular adaptations in Preeclampsia M. Charakida
12:00-12:20 Discussion
12:20 Prize for the best oral presentation Closing remarks
Related Products
